Jewell Laboratories

Alzeca Biosciences

This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.

Spherics

This pharmaceutical company develops oral drug delivery technologies to create improved therapeutic products for patients with central nervous system disorders and other medical conditions.

Shape Therapeutics

The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.

NX Pharmagen

This company develops molecular diagnostic tests and imaging agents for physicians and healthcare payers to improve cancer and maternal-fetal health outcomes.

Drug Delivery

This company develops ingestible technology for drug delivery and health monitoring to serve patients and healthcare providers.

LipoScience

This company develops nuclear magnetic resonance diagnostic tests and clinical analysers for laboratories and physicians to manage patient cardiovascular and metabolic disease risks.

Cognition Therapeutics

This company develops oral small-molecule medications for patients with neurodegenerative disorders such as Alzheimer's disease and dementia with Lewy bodies.

Tacit Therapeutics

This company develops RNA trans-splicing medicines to repair genetic mutations for patients with inherited neurological diseases and other complex gene-mediated conditions.